Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Regadenoson for a Stress Echocardiogram Protocol Using Speckle Tracking Imaging

NCT02130453 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT02130453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02130453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Regadenoson for a Stress Echocardiogram Protocol Using Speckle Tracking Imaging
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2014
Completion date
June 28, 2024
Enrollment
161 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemia